Sodium 2-(2-aminophenyl)-2-oxoacetate, 95.0%, 1g

2-methyl-3-[(2-pyridinylmethyl)amino]benzoic acid, 95.0%, 5g

3-Bromo-4-iodo-1-methyl-1H-pyrazole, 98%, 5g

3-(2-Methoxyethoxy)benzonitrile, 97%, 5g

(2S)-N-[(1S)-1-(Hydroxydiphenylmethyl)-3-methylbutyl]-2-pyrrolidinecarboxamide>98.0%(HPLC)(T)1g

7-ACETOXY-4-METHYLCOUMARIN, 97.0%, 100g

(R)-4-(TERT-BUTYL)-N-(6-(2,3-DIHYDROXYPROPOXY)-5-(2-METHOXYPHENOXY)-2-(4-METHOXYPHENYL)PYRIMIDIN-4-YL)BENZENESULFONAMIDE, 95%, 5mg

1-(2-Amino-6,7-dihydro-4H-thiazolo[5,4-c]pyridin-5-yl)-ethanone, 95.0%, 1g

Cappa per incubazione TH 15, 1 pezzo

1-Benzyl-3-piperidone, 95.0%, 10g

6-Iodoisoindolin-1-one, 95.0%, 1g

3-BROMO-4-METHOXY-1H-INDAZOLE, 95%, 1g

2-phenyl-3,4-dihydro-2H-1-benzopyran-4-one, 95.0%, 5g